SMARCC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.980800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.382400E-02
Normal-vs-Stage2
7.209100E-04
Normal-vs-Stage3
3.763100E-03
Normal-vs-Stage4
8.511200E-01
Stage1-vs-Stage2
3.837400E-01
Stage1-vs-Stage3
1.630210E-01
Stage1-vs-Stage4
1.093040E-01
Stage2-vs-Stage3
3.443900E-02
Stage2-vs-Stage4
1.081360E-01
Stage3-vs-Stage4
3.794200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.772100E-04
Normal-vs-AfricanAmerican
2.109600E-01
Normal-vs-Asian
2.463600E-02
Caucasian-vs-AfricanAmerican
9.587600E-01
Caucasian-vs-Asian
8.199200E-01
AfricanAmerican-vs-Asian
8.443800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.203200E-04
Normal-vs-Female
1.570490E-04
Male-vs-Female
8.098600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.656980E-01
Normal-vs-Age(41-60Yrs)
3.112000E-01
Normal-vs-Age(61-80Yrs)
1.010870E-04
Normal-vs-Age(81-100Yrs)
8.782000E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.182000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.269800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.380200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.167790E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.401430E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.973800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.590800E-04
Normal-vs-Daily Drinker
1.317200E-03
Normal-vs-Weekly Drinker
1.488790E-01
Normal-vs-Occasional Drinker
2.170400E-01
Normal-vs-Social Drinker
1.142990E-01
Non Drinker-vs-Daily Drinker
6.882400E-01
Non Drinker-vs-Weekly Drinker
8.758000E-01
Non Drinker-vs-Occasional Drinker
1.668030E-01
Non Drinker-vs-Social Drinker
3.026000E-01
Daily Drinker-vs-Weekly Drinker
6.177800E-01
Daily Drinker-vs-Occasional Drinker
1.088400E-01
Daily Drinker-vs-Social Drinker
1.983820E-01
Weekly Drinker-vs-Occasional Drinker
2.626200E-01
Weekly Drinker-vs-Social Drinker
3.967600E-01
Occasional Drinker-vs-Social Drinker
7.724000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.899400E-01
Normal-vs-Grade 2
6.411800E-01
Normal-vs-Grade 3
1.263230E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.691000E-01
Grade 1-vs-Grade 3
9.174500E-02
Grade 1-vs-Grade 4
3.899400E-01
Grade 2-vs-Grade 3
2.818400E-01
Grade 2-vs-Grade 4
6.411800E-01
Grade 3-vs-Grade 4
1.263230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.392300E-04
Normal-vs-NonDiabetic
1.509800E-01
Diabetic-vs-NonDiabetic
9.204000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.538030E-01
Normal-vs-NoPancreatitis
1.962560E-04
Pancreatitis-vs-NoPancreatitis
9.174400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.618000E-04
Normal-vs-N1
3.821600E-04
N0-vs-N1
7.353600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.583000E-01
Normal-vs-TP53-NonMutant
3.058400E-01
TP53-Mutant-vs-TP53-NonMutant
2.905800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
